(Q48785189)

15 February 2018

title

Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine. (English)

1 reference

15 February 2018

main subject

Lyme disease

0 references

author

Reinhard K. Straubinger

1

1 reference

15 February 2018

author name string

Dharma Rao T

2

1 reference

15 February 2018

Davidson E

3

1 reference

15 February 2018

Summers BA

4

1 reference

15 February 2018

Jacobson RH

5

1 reference

15 February 2018

Frey AB

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 October 2001

1 reference

15 February 2018

number of pages

13

1 reference

inferred from page(s)

published in

Vaccine

1 reference

15 February 2018

volume

20

1 reference

15 February 2018

issue

1-2

1 reference

15 February 2018

page(s)

181-193

1 reference

15 February 2018

The Spirochetal Etiology of Lyme Disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

The diagnosis of Lyme disease: rewards and perils.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Perspective on the development of vaccines against Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Active immunization of hamsters against experimental infection with Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Soluble proteins isolated from Borrelia burgdorferi by extraction with Triton X-114 confer resistance to experimental infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Genetic heterogeneity of Borrelia burgdorferi in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Deletion in the genes encoding outer surface proteins OspA and OspB of Borrelia garinii isolated from patients in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Protection from Lyme neuroborreliosis in nonhuman primates with a multiantigenic vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Experimental Lyme disease in dogs produces arthritis and persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900251-1

7 January 2021

10.1016/S0264-410X(01)00251-1

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

11567763

1 reference

15 February 2018